Carlisle holder plans Rule 144 sale of 6,049 shares

Carlisle Companies has a holder planning to sell 6,049 shares of common stock under Rule 144 through UBS Financial Services on the NYSE, with an aggregate market value of 2,419,600.

Accepted by SEC EDGAR 02/12/2026 - 06:00 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Carlisle Companies has a holder planning to sell 6,049 shares of common stock under Rule 144 through UBS Financial Services on the NYSE, with an aggregate market value of 2,419,600. Shares outstanding were 41,785,774 common shares at the time referenced.

The shares come from prior equity awards, including stock options exercised on 02/12/2016 and various restricted stock awards and performance stock units granted between 08/24/2020 and 02/08/2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Carlisle (CSL) Rule 144 filing report?

The filing reports a planned Rule 144 sale of Carlisle common stock. A holder intends to sell 6,049 shares on the NYSE, with an aggregate market value of about 2,419,600, using UBS Financial Services as broker.

How many Carlisle (CSL) shares are planned for sale under Rule 144?

The notice covers 6,049 Carlisle common shares to be sold. These shares are to be sold through UBS Financial Services on the NYSE, with the approximate sale date listed as 02/12/2026 and an aggregate market value of 2,419,600.

What is the aggregate market value of the planned Carlisle (CSL) sale?

The planned Rule 144 sale has an aggregate market value of 2,419,600. This value corresponds to 6,049 Carlisle common shares to be sold on the NYSE through UBS Financial Services, as indicated in the securities information table.

How many Carlisle (CSL) shares were outstanding when this Rule 144 sale was noted?

The filing lists 41,785,774 Carlisle common shares outstanding. This figure provides a baseline context relative to the 6,049 shares covered by the planned Rule 144 sale described in the notice for trading on the NYSE.

How were the Carlisle (CSL) shares in the Rule 144 notice originally acquired?

The shares come from equity compensation and an option exercise. Sources include an option exercise dated 02/12/2016 and multiple restricted stock awards and performance stock units granted on 02/02/2024, 02/04/2023, 02/08/2025, and 08/24/2020.

When is the approximate sale date for the Carlisle (CSL) Rule 144 shares?

The approximate sale date listed is 02/12/2026. On or around this date, the holder plans to sell 6,049 shares of Carlisle common stock on the NYSE through UBS Financial Services, subject to market conditions and Rule 144 requirements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001948611
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Carlisle Companies Inc
SEC File Number	001-09278
Address of Issuer	16430 N. SCOTTSDALE RD SCOTTSDALE ARIZONA 85254
Phone	480-781-5000
Name of Person for Whose Account the Securities are To Be Sold	Stephen Schwar
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	6049	2419600	41785774	02/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/12/2016	Option Exercise	Issuer			1500	02/12/2026	Cash
Common Stock	02/02/2024	RSA	Issuer			237	02/02/2024	NA
Common Stock	02/02/2024	PSU	Issuer			456	02/02/2024	NA
Common Stock	02/04/2023	RSA	Issuer			195	02/04/2023	NA
Common stock	02/04/2023	PSU	Issuer			367	02/04/2023	NA
Common Stock	02/08/2025	RSA	Issuer			763	02/08/2025	NA
Common Stock	02/08/2025	PSU	Issuer			1822	02/08/2025	NA
Common stock	08/24/2020	RSA	Issuer			709	08/24/2020	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for Stephen Schwar
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)